(1)
Lebwohl, M.; Stein Gold, L.; Gooderham, M. J.; Papp, K. A.; Ferris, L. K.; Adam, D. N.; Hong, H. C.- ho; Kircik, L. H.; Zirwas, M.; Burnett, P.; Higham, R. Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults With Chronic Plaque Psoriasis From a 52-Week, Phase 2 Open-Label Safety Trial. J of Skin 2023, 7, s218.